Haleon plc Stock

Equities

HLN

GB00BMX86B70

Pharmaceuticals

Market Closed - London S.E. 11:35:24 2024-07-02 am EDT 5-day change 1st Jan Change
322.6 GBX -0.65% Intraday chart for Haleon plc -3.50% +0.30%
Sales 2024 * 11.45B 14.53B Sales 2025 * 11.94B 15.15B Capitalization 29.65B 37.63B
Net income 2024 * 1.49B 1.89B Net income 2025 * 1.71B 2.17B EV / Sales 2024 * 3.27 x
Net Debt 2024 * 7.82B 9.92B Net Debt 2025 * 7.06B 8.96B EV / Sales 2025 * 3.07 x
P/E ratio 2024 *
20.1 x
P/E ratio 2025 *
17.3 x
Employees 25,408
Yield 2024 *
1.92%
Yield 2025 *
2.21%
Free-Float 81.7%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.65%
1 week-3.50%
1 month-0.77%
3 months-3.15%
6 months+0.30%
Current year+0.30%
More quotes
1 week
320.00
Extreme 320
334.70
1 month
319.84
Extreme 319.8398
335.50
Current year
308.37
Extreme 308.3696
371.20
1 year
306.80
Extreme 306.8
371.20
3 years
241.17
Extreme 241.1735
371.20
5 years
241.17
Extreme 241.1735
371.20
10 years
241.17
Extreme 241.1735
371.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 21-07-21
Director of Finance/CFO 52 21-11-30
Chief Tech/Sci/R&D Officer - 21-12-15
Members of the board TitleAgeSince
Director/Board Member - 22-07-17
Director/Board Member 64 22-07-17
Director/Board Member 57 22-07-17
More insiders
Date Price Change Volume
24-07-02 322.6 -0.65% 11,763,130
24-07-01 324.7 +0.65% 15,911,420
24-06-28 322.6 -1.32% 16,223,290
24-06-27 326.9 -1.42% 15,246,380
24-06-26 331.6 -0.27% 16,917,530

Delayed Quote London S.E., July 02, 2024 at 11:35 am EDT

More quotes
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.226 GBP
Average target price
3.646 GBP
Spread / Average Target
+13.03%
Consensus